Advertisement

Engraftment Syndrome: Clinical Features and Predictive Factors in Autologous Stem Cell Transplant

  • V. Sheth
  • R. Jain
  • A. Gore
  • A. Ghanekar
  • T. Saikia
Original Article
  • 87 Downloads

Abstract

Engraftment Syndrome (ES) maybe observed in patients who undergo autologous stem cell transplant (SCT). To investigate clinical criteria for ES diagnosis and analyse the risk factors for this complication, we reviewed all auto-SCT cases (Lymphoma and Myeloma) performed during the past 9 years at two tertiary care centres. We analysed all patients with a non-infectious fever, developed within 7 days of engraftment (first day of ANC of 500 on two consecutive days) in 178 patients undergoing autologous stem cell transplant. A total of 46/178 (25.8%) patients developed non-infectious fever and one or more clinical signs of ES within 7 days of engraftment. In all, 29 (61%) fulfilled the Maiolino and 12 (26%) the Spitzer criteria. The incidence of engraftment syndrome using the Maiolino criteria in our study was 29 (15%), which compares well with Spanish study (13% using same criteria) and the original Maiolino study (20%). All patients with ES satisfactorily recovered and discharged with a median of 20 days from hospital. There was no significant difference in number of days of hospitalisation and days of antibiotics between the ES and non ES arms. All patients recovered without any morbidity and only 1 (2%) patient required readmission for fungal pneumonitis. 8 (17%) patients required ICU admission due to delay in initiation of steroids. None of the factors including number of chemotherapy cycles, conditioning regime, disease status, CD34 collection, growth factors and day of WBC engraftment except female (p = 0.064) were statistically significant (in univariate or multivariate analysis). Our study shows that engraftment syndrome is common in autologous transplant setting. Maiolino criteria to diagnose ES is more sensitive in our setting. If detected and treated early there is not much morbidity or mortality related to ES.

Keywords

Engraftment syndrome Autologous stem cell transplantation Engraftment fever Non-infectious fever 

Notes

Author’s Contribution

VS, RJ and AG contributed equally, wrote manuscript, analyzed data, designed study; AG, treated patients; TS, mentored paper, treated patients.

Compliance with Ethical Standards

Conflict of interest

No conflict of interest or funding to be declared.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Lee CK, Gingrich RD, Hohl RJ et al (1995) Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 16:175–182PubMedGoogle Scholar
  2. 2.
    Spitzer TR et al (2001) Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 27:893–898CrossRefPubMedGoogle Scholar
  3. 3.
    Rabinowitz J, Petros WP, Stuart AR et al (1993) Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Blood 81(9):2452–2459PubMedGoogle Scholar
  4. 4.
    Spitzer TR (2015) Engraftment syndrome: double-edged sword of hematopoietic cell transplants. Bone Marrow Transplant 50:469–475CrossRefPubMedGoogle Scholar
  5. 5.
    Capizzi SA, Kumar S, Huneke NE et al (2001) Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 27:1299–1303CrossRefPubMedGoogle Scholar
  6. 6.
    Maiolino A, Biasoli I, Lima J et al (2003) Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant 31:393–397CrossRefPubMedGoogle Scholar
  7. 7.
    Dispenzieri A, Lacy MQ, Hayman SR et al (2008) Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 80:397–406CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Carreras E, Fernandez-Aviles F, Silva L et al (2010) Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center. Bone Marrow Transplant 45:1417–1422CrossRefPubMedGoogle Scholar
  9. 9.
    Moreb JS, Kubilis PS, Mullins DL, Myers L, Youngblood M, Hutcheson C (1997) Increased frequency of auto-aggression syndrome associated with autologous stem cell transplantation in breast cancer patients. Bone Marrow Transplant 19:101–106CrossRefPubMedGoogle Scholar
  10. 10.
    Edenfield WJ, Moores LK, Goodwin G et al (2000) An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose. Bone Marrow Transplant 25:405–409CrossRefPubMedGoogle Scholar
  11. 11.
    Nurnberger W, Willers R, Burdach S et al (1997) Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol 74:221–224CrossRefPubMedGoogle Scholar
  12. 12.
    Cahill RA, Spitzer TR, Mazumder A et al (1996) Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 18:177–184PubMedGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2017

Authors and Affiliations

  • V. Sheth
    • 1
  • R. Jain
    • 1
    • 2
  • A. Gore
    • 1
  • A. Ghanekar
    • 1
  • T. Saikia
    • 1
  1. 1.Department of Bone Marrow Transplantation and Medical OncologyPrince Aly Khan HospitalMumbaiIndia
  2. 2.Hematology and Bone Marrow Transplant DepartmentJaslok Hospital and Research CentreMumbaiIndia

Personalised recommendations